Question

How much do drug companies pay doctors?

Drug and device manufacturers reported paying doctors and practitioners $17,307,111,322 in general payments between 2019 and 2025, across 87,393,359 separate payments to 1,693,971 people, according to CMS Open Payments.

They reported a further $610,582,922 in research funding and $2,201,126,553 in ownership and investment interests, which are different transactions and are not added to the first figure.

Data retrieved September 25, 2026

The figures behind this

1 more column on a wider screen

General payments reported to CMS by program year, 2019–2025
Program year	Doctors paid	General payments	Research payments
2019	631,708	$2.4 billion$2,433,781,271	$101.9 million$101,892,335
2020	502,760	$1.7 billion$1,687,784,050	$87.2 million$87,206,564
2021	781,493	$2.3 billion$2,284,708,676	$86.1 million$86,066,142
2022	876,051	$2.7 billion$2,732,382,058	$83.4 million$83,448,210
2023	947,021	$2.5 billion$2,528,284,907	$82.5 million$82,469,397
2024	996,074	$2.7 billion$2,745,100,006	$106.4 million$106,402,782
2025	1,029,095	$2.9 billion$2,895,070,353	$63.1 million$63,097,491

Where to go next

Sources

Open Payments — payments grouped by physician — Centers for Medicare & Medicaid Services · U.S. Government work · retrieved September 25, 2026

Compiled automatically from Open Payments — payments grouped by physician by a checked SQL query · Editor: Kian O'Connor · How this site is built